Janney Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-178,313
Closed -$12.8M 185
2016
Q4
$12.8M Sell
178,313
-34,635
-16% -$2.57M 0.59% 70
2016
Q3
$16.8M Sell
212,948
-17,574
-8% -$1.43M 0.76% 60
2016
Q2
$19.2M Buy
230,522
+13,160
+6% +$1.17M 1.02% 43
2016
Q1
$20M Sell
217,362
-2,472
-1% -$223K 1.07% 33
2015
Q4
$22.2M Buy
219,834
+1,054
+0.5% +$110K 0.98% 39
2015
Q3
$21.5M Buy
218,780
+7,646
+4% +$849K 0.98% 38
2015
Q2
$24.7M Buy
211,134
+3,080
+1% +$337K 3.47% 9
2015
Q1
$20.4M Buy
208,054
+4,390
+2% +$446K 0.68% 52
2014
Q4
$19.2M Buy
203,664
+11,130
+6% +$1.15M 1.11% 34
2014
Q3
$20.5M Buy
192,534
+189,408
+6,059% +$18.5M 1.24% 17
2014
Q2
$259K Buy
+3,126
New +$243K 0.02% 179

Other funds holding GILD

Janney Capital Management's GILD Position: Q1 2017 in Review

Janney Capital Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 178,313 shares — an estimated $12.8M sold.

Janney Capital Management first reported a position in GILD in Q2 2014 and held it in 11 quarters. The position peaked at $24.7M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Janney Capital Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Janney Capital Management sold 178,313 Gilead Sciences shares in Q1 2017, an estimated $12.8M.
  • Janney Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 11 quarters.
  • Janney Capital Management's Gilead Sciences position peaked at $24.7M in Q2 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Janney Capital Management's 13F filing for Q1 2017, filed 26 Apr 2017.